Stockreport

Virpax Pharmaceuticals Reports 2023 Year-End Results [Yahoo! Finance]

Virpax Pharmaceuticals, Inc.  (VRPX) 
PDF developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announ [Read more]